| Ranibizumab for neovascular age-related macular degeneration PJ Rosenfeld, DM Brown, JS Heier, DS Boyer, PK Kaiser, CY Chung, ... New England Journal of Medicine 355 (14), 1419-1431, 2006 | 7172 | 2006 |
| Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label … SD Schwartz, CD Regillo, BL Lam, D Eliott, PJ Rosenfeld, NZ Gregori, ... The Lancet 385 (9967), 509-516, 2015 | 1499 | 2015 |
| Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin®) for neovascular age-related macular degeneration PJ Rosenfeld, AA Moshfeghi, CA Puliafito Ophthalmic Surgery, Lasers and Imaging Retina 36 (4), 331-335, 2005 | 1387 | 2005 |
| An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration AE Fung, GA Lalwani, PJ Rosenfeld, SR Dubovy, S Michels, WJ Feuer, ... American journal of ophthalmology 143 (4), 566-583. e2, 2007 | 1252 | 2007 |
| A cellular DNA-binding protein that activates eukaryotic transcription and DNA replication KA Jones, JT Kadonaga, PJ Rosenfeld, TJ Kelly, R Tjian Cell 48 (1), 79-89, 1987 | 1181 | 1987 |
| A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study GA Lalwani, PJ Rosenfeld, AE Fung, SR Dubovy, S Michels, W Feuer, ... American journal of ophthalmology 148 (1), 43-58. e1, 2009 | 1179 | 2009 |
| Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration: twelve-week results of an uncontrolled open-label clinical study S Michels, PJ Rosenfeld, CA Puliafito, EN Marcus, AS Venkatraman Ophthalmology 112 (6), 1035-1047. e9, 2005 | 997 | 2005 |
| Optical coherence tomography angiography: a comprehensive review of current methods and clinical applications AH Kashani, CL Chen, JK Gahm, F Zheng, GM Richter, PJ Rosenfeld, ... Progress in retinal and eye research 60, 66-100, 2017 | 920 | 2017 |
| Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion: twelve-month study results JA Haller, F Bandello, R Belfort Jr, MS Blumenkranz, M Gillies, J Heier, ... Ophthalmology 118 (12), 2453-2460, 2011 | 903 | 2011 |
| The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwide AE Fung, PJ Rosenfeld, E Reichel British Journal of Ophthalmology 90 (11), 1344-1349, 2006 | 811 | 2006 |
| Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin®) for macular edema from central retinal vein occlusion PJ Rosenfeld, AE Fung, CA Puliafito Ophthalmic Surgery, Lasers and Imaging Retina 36 (4), 336-339, 2005 | 742 | 2005 |
| Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration RM Rich, PJ Rosenfeld, CA Puliafito, SR Dubovy, JL Davis, HW Flynn Jr, ... Retina 26 (5), 495-511, 2006 | 693 | 2006 |
| Consensus definition for atrophy associated with age-related macular degeneration on OCT: classification of atrophy report 3 SR Sadda, R Guymer, FG Holz, S Schmitz-Valckenberg, CA Curcio, ... Ophthalmology 125 (4), 537-548, 2018 | 684 | 2018 |
| Consensus nomenclature for reporting neovascular age-related macular degeneration data: consensus on neovascular age-related macular degeneration nomenclature study group RF Spaide, GJ Jaffe, D Sarraf, KB Freund, SR Sadda, G Staurenghi, ... Ophthalmology 127 (5), 616-636, 2020 | 614 | 2020 |
| Ranibizumab for treatment of neovascular age-related macular degeneration: a phase I/II multicenter, controlled, multidose study JS Heier, AN Antoszyk, PR Pavan, SR Leff, PJ Rosenfeld, TA Ciulla, ... Ophthalmology 113 (4), 633-642. e4, 2006 | 531 | 2006 |
| Lutein+ zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial Age-Related Eye Disease Study 2 (AREDS2) Research Group Jama 309 (19), 2005-2015, 2013 | 510 | 2013 |
| Novel method for analyzing snellen visual acuity measurements NZ Gregori, W Feuer, PJ Rosenfeld Retina 30 (7), 1046-1050, 2010 | 510 | 2010 |
| Factors associated with reduced visual acuity during long-term follow-up of patients with idiopathic central serous chorioretinopathy RH Loo, IU Scott, HW Flynn Jr, JDM Gass, TG Murray, ML Lewis, ... Retina 22 (1), 19-24, 2002 | 504 | 2002 |
| Predicted biological activity of intravitreal VEGF Trap MW Stewart, PJ Rosenfeld British Journal of Ophthalmology 92 (5), 667-668, 2008 | 495 | 2008 |
| Vision loss after intravitreal injection of autologous “stem cells” for AMD AE Kuriyan, TA Albini, JH Townsend, M Rodriguez, HK Pandya, ... New England Journal of Medicine 376 (11), 1047-1053, 2017 | 488 | 2017 |
